About the job
Join Axsome Therapeutics, a pioneering biopharmaceutical company dedicated to transforming the treatment landscape for central nervous system (CNS) disorders. Our commitment to identifying significant gaps in care drives us to develop innovative therapies that harness novel mechanisms of action, resulting in substantial improvements in patient outcomes. Our cutting-edge neuroscience portfolio includes FDA-approved therapies for major depressive disorder, excessive daytime sleepiness linked to narcolepsy and obstructive sleep apnea, and migraines, alongside multiple late-stage development programs targeting a wide array of serious neurological and psychiatric conditions affecting over 150 million individuals across the United States. Together, we strive to tackle some of the most pressing challenges of brain health, enabling patients and their families to thrive. For further details, visit www.axsome.com and connect with us on LinkedIn.
